key: cord-0686405-53vgz1dr
authors: Randall, Melanie; Minahan, Thomas; Mesisca, Michael; Gnass, Silvia
title: Nosocomial Methicillin-Resistant Staphylococcus aureus Bacteremia in Incarcerated Patients with Severe COVID-19 Infection
date: 2020-09-20
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2020.09.005
sha: c71ef354cc0cc0f2e7aebd16662e5e758ad0e71a
doc_id: 686405
cord_uid: 53vgz1dr

nan

As Coronavirus disease 2019 (COVID-19) infections swiftly entered the correctional healthcare system, routine infectious disease management changed dramatically.

Personal Protective Equipment (PPE) became universal in order to decrease viral spread among a crowded and vulnerable population. (1, 2) We theorized that the increase in PPE use would decrease nosocomial infections overall. However, within three months, three inmates from the same local state prison admitted as inpatients to our county hospital for COVID-19 infections, developed nosocomial methicillin-resistant Staphylococcus aureus Initially, he was admitted to the intensive care unit but improved and was transferred to the medical floor. He was treated with systemic steroids but was not a candidate for Remdesivir. On hospital day four, he had a cardiopulmonary arrest and was transferred back to the intensive care unit. On hospital day nine, blood cultures were positive for MRSA. On hospital day ten, the patient died from pneumonia after the family signed a Do-Not-Resuscitate order. We write this letter to the editor to highlight a series of patients that could lead to further research into the relationship between the COVID-19 virus and other infections. As information about the COVID-19 virus continues to grow, this may help to identify correlations and interactions with the virus and guide hospital policies to decrease associated nosocomial infections.

Flattening the Curve for Incarcerated Populations -Covid-19 in Jails and Prisons

COVID-19 in Prisons and Jails in the United States